Financials
- Market Capitalization 466.05 M
- Employee 79
- Founded 2016
- CEO N/A
- Website www.preludetx.com
- Headquarter Delaware, United States
- FIGI BBG00K7JY2Q6
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2.25
市销率
18.38
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2910 | EDIT Editas Medicine, Inc. - Common Stock | 3.35 USD | +1.52% | +7.03% | +28.85% | +26.42% | 514.49 M USD | ||
| 2919 | CCCC C4 Therapeutics, Inc. - Common Stock | 4.10 USD | -3.30% | +3.02% | +18.84% | +62.06% | 504.40 M USD | ||
| 2935 | EVMN Evommune, Inc. Common Stock | 13.42 USD | -0.07% | -5.16% | +20.79% | -22.52% | 487.04 M USD | ||
| 2948 | PRTA Prothena Corporation plc - Ordinary Shares | 9.31 USD | +2.42% | +0.32% | +7.75% | +12.58% | 477.95 M USD |